Beta Bionics BBNX
NASDAQ BBNX
$19.50 -0.51 (-2.55%)
As of: Aug 20, 2026 · 3:59 PM EDT

Beta Bionics (BBNX) Gross Margin (2024 - 2026)

Beta Bionics (BBNX) posted Gross Margin of 59.04% for Q2 2026, down 0.76% sequentially from 59.5% in Q1 2026, and up 524.0% YoY from 9.46% in Q2 2025.

Beta Bionics (BBNX) Gross Margin (2024 - 2026) Analysis & Trends

Beta Bionics has reported Gross Margin for 3 years, with the latest figure at 59.04% in Q2 2026.

  • Quarterly Gross Margin rose 524.0% year-over-year to 59.04% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 58.31% (up 438.0% YoY) and the FY2025 annual result came in at 55.4%, up 29.0% from the prior year.
  • Gross Margin retreated to 59.04% in Q2 2026 per BBNX's latest filing, from 59.5% in the prior quarter.
  • Over five years, Gross Margin peaked at 59.5% in Q1 2026 and troughed at 50.86% in Q1 2025.
  • A 3-year average of 55.76% and a median of 55.58% in 2025 frame the typical range for Gross Margin.
  • The sharpest annual moves came in 2025 and 2026: Gross Margin plunged 482 bps in 2025, then surged 864 bps in 2026.
  • Over 3 years, Gross Margin stood at 57.19% in 2024, then increased by 3 bps to 58.98% in 2025, then rose by 0 bps to 59.04% in 2026.
  • According to Business Quant data, Gross Margin over the past three periods registered 59.04%, 59.5%, and 58.98% for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 57.71%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 68.27%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 65.35%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 70.71%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 77.46%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 63.44%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 41.17%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 47.38%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 45.84%
10 Beta Bionics 865.29 Mn 684.80 Mn 18.90 Mn 59.04%

Historic Data

Download Data
DateValue
Jun 30, 2026 59.04%
Mar 31, 2026 59.50%
Dec 31, 2025 58.98%
Sep 30, 2025 55.48%
Jun 30, 2025 53.80%
Mar 31, 2025 50.86%
Dec 31, 2024 57.19%
Sep 30, 2024 53.36%
Jun 30, 2024 53.73%
Mar 31, 2024 55.68%